Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Genetic Signatures jumps 20pc on FDA update, Proteomics reveals new patent in Japan
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as Proteomics inks Sonic deal
News
CLOSING BELL: Smiles all round as the ASX holds onto early gains to finish 0.78% heavier
Health & Biotech
ScoPo’s (he’s back) Powerplays: ASX health stocks fall, Volpara ‘elephants’ strategy pays off
Health & Biotech
ASX Health Stocks: Proteomics’ blood test PromarkerD effective with diabetes drug Canagliflozin
News
Market Highlights: Crude prices tumble 5pc; and 5 ASX small caps to watch on Wednesday
Health & Biotech
Q+A: Proteomics MD Richard Lipscombe on its potential US breakthrough with Sonic Healthcare
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines update
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: Brace yourselves… even the clowns in charge don’t know what’s coming.
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop as Neuren surges 60% on US FDA approval
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts
Health & Biotech
ScoPo’s Powerplays: ASX health stocks sprout 4.6%, as Volpara soars on first positive cash flow
Health & Biotech
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Health & Biotech
ScoPo’s Powerplays: Volpara leads a minor ASX small cap health sector renaissance
Health & Biotech